Related Experiment Videos
Brain atrophy in 18 patients with Down syndrome: a CT study
G D Pearlson1, A C Warren, S E Starkstein
1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD 21205.
AJNR. American Journal of Neuroradiology
|July 1, 1990
Summary
Individuals with Down syndrome show brain changes similar to Alzheimer disease after age 40. Specific brain measurements accurately predicted dementia in Down syndrome patients, differing from normal aging patterns.
Area of Science:
- Neurology
- Neuroimaging
- Genetics
Background:
- Individuals with Down syndrome (DS) have a high risk of developing Alzheimer disease (AD) neuropathology after age 40.
- This increased risk is linked to genetic factors on chromosome 21.
- Understanding brain changes in DS is crucial for early detection and intervention.
Purpose of the Study:
- To compare brain atrophy patterns in individuals with Down syndrome and healthy controls using CT scans.
- To investigate the relationship between brain structure, age, and cognitive status in Down syndrome.
- To determine if specific brain measurements can predict dementia in the Down syndrome population.
Main Methods:
- Computed tomography (CT) scans of 18 individuals with Down syndrome (ages 26-70) and 175 healthy controls were analyzed.
- Cortical and subcortical atrophy were assessed, focusing on the suprasellar cistern ratio as a marker for mesial temporal lobe atrophy.
- Brain measurements were correlated with age and cognitive status, including dementia assessment.
Main Results:
- A distinct pattern of increased brain abnormality with age was observed in individuals with Down syndrome compared to controls.
- The suprasellar cistern ratio correlated significantly with cognitive impairment severity, even after accounting for age.
- The suprasellar cistern ratio predicted dementia status in Down syndrome subjects with over 75% accuracy.
Conclusions:
- Brain imaging reveals age-related structural changes in Down syndrome that differ from normal aging.
- Suprasellar cistern ratio is a reliable indicator of mesial temporal lobe atrophy and predicts dementia in Down syndrome.
- These findings highlight the utility of neuroimaging markers for assessing Alzheimer disease risk and progression in Down syndrome.